Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agreement of serum, red blood cell, and urine magnesium methods for diagnosing hypomagnesemia in ICU patients
IRCT20231220060484N3Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of magnesium sulfate in hypomagnesaemia, sponsored by Islamic Azad University. Primary endpoint: Investigation of hypomagnesemia in intensive care unit patients. Started May 2024; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
hypomagnesaemia
Beyond the preview
Go deeper on IRCT20231220060484N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231220060484N3.